739 related articles for article (PubMed ID: 30064868)
41. Real-World Outcomes of Acute Ischemic Stroke Treatment with Intravenous Recombinant Tissue Plasminogen Activator.
Betts KA; Hurley D; Song J; Sajeev G; Guo J; Du EX; Paschoalin M; Wu EQ
J Stroke Cerebrovasc Dis; 2017 Sep; 26(9):1996-2003. PubMed ID: 28689999
[TBL] [Abstract][Full Text] [Related]
42. Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischemic stroke.
Rubiera M; Alvarez-Sabín J; Ribo M; Montaner J; Santamarina E; Arenillas JF; Huertas R; Delgado P; Purroy F; Molina CA
Stroke; 2005 Jul; 36(7):1452-6. PubMed ID: 15947260
[TBL] [Abstract][Full Text] [Related]
43. Does symptom onset to primary stroke center time goals affect stroke outcome?
Chee B; Raman R; Ernstrom K; Guzik AK; Hemmen TM; Rapp KS; Meyer BC; Meyer DM
J Stroke Cerebrovasc Dis; 2014; 23(5):993-1000. PubMed ID: 24103670
[TBL] [Abstract][Full Text] [Related]
44. Utilization of Intravenous Tissue Plasminogen Activator and Reasons for Nonuse in Acute Ischemic Stroke in Saudi Arabia.
Al Khathaami AM; Al Bdah B; Tarawneh M; Alskaini M; Alotaibi F; Alshalan A; Almuhraj M; Aldaham D; Alotaibi N
J Stroke Cerebrovasc Dis; 2020 May; 29(5):104761. PubMed ID: 32173225
[TBL] [Abstract][Full Text] [Related]
45. Does Prior Antiplatelet Treatment Increase the Risk of Hemorrhagic Transformation and Unfavorable Outcome on Day 90 after Intravenous Thrombolysis in Acute Ischemic Stroke Patients?
Chen S; Lu X; Zhang W; Han Z; Yang W; Huang X; Jin X; Wang Z; Liang H; Qiu W; Cheng J; Shao B
J Stroke Cerebrovasc Dis; 2016 Jun; 25(6):1366-70. PubMed ID: 26996750
[TBL] [Abstract][Full Text] [Related]
46. Neutrophil-to-Lymphocyte Ratio and Response to Intravenous Thrombolysis in Patients with Acute Ischemic Stroke.
Pektezel MY; Yilmaz E; Arsava EM; Topcuoglu MA
J Stroke Cerebrovasc Dis; 2019 Jul; 28(7):1853-1859. PubMed ID: 31072698
[TBL] [Abstract][Full Text] [Related]
47. Intravenous Thrombolysis After Idarucizumab Application in Acute Stroke Patients-A Potentially Increased Sensitivity of Thrombi to Lysis?
Pretnar Oblak J; Sabovic M; Frol S
J Stroke Cerebrovasc Dis; 2019 Mar; 28(3):768-773. PubMed ID: 30527792
[TBL] [Abstract][Full Text] [Related]
48. Outcome of stroke patients receiving different doses of recombinant tissue plasminogen activator.
Ong CT; Wong YS; Wu CS; Su YH
Drug Des Devel Ther; 2017; 11():1559-1566. PubMed ID: 28572721
[TBL] [Abstract][Full Text] [Related]
49. Characteristics of the Drip-and-Ship Paradigm for Patients with Acute Ischemic Stroke in South Korea.
Park MS; Lee JS; Park TH; Cho YJ; Hong KS; Park JM; Kang K; Lee KB; Kim JG; Lee SJ; Lee J; Choi KH; Kim JT; Cho KH; Oh MS; Yu KH; Lee BC; Cha JK; Kim DH; Nah HW; Lee J; Kim DE; Ryu WS; Kim BJ; Han MK; Bae HJ; Song SK; Choi JC
J Stroke Cerebrovasc Dis; 2016 Nov; 25(11):2678-2687. PubMed ID: 27480820
[TBL] [Abstract][Full Text] [Related]
50. Low- versus Standard-Dose Intravenous Tissue-Type Plasminogen Activator for Acute Ischemic Stroke: An Updated Meta-Analysis.
Liu H; Zheng H; Cao Y; Pan Y; Wang D; Zhang R; You S; Zhang X; Li S; Tong X; Liu CF; Wang Y
J Stroke Cerebrovasc Dis; 2018 Apr; 27(4):988-997. PubMed ID: 29224744
[TBL] [Abstract][Full Text] [Related]
51. Admission leukocytosis in acute cerebral ischemia: influence on early outcome.
Nardi K; Milia P; Eusebi P; Paciaroni M; Caso V; Agnelli G
J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):819-24. PubMed ID: 21703875
[TBL] [Abstract][Full Text] [Related]
52. Low Alberta stroke program early computed tomography score within 3 hours of onset predicts subsequent symptomatic intracranial hemorrhage in patients treated with 0.6 mg/kg Alteplase.
Hirano T; Sasaki M; Tomura N; Ito Y; Kobayashi S;
J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):898-902. PubMed ID: 21737309
[TBL] [Abstract][Full Text] [Related]
53. Does large vessel occlusion affect clinical outcome in stroke with mild neurologic deficits after intravenous thrombolysis?
Zhu W; Churilov L; Campbell BCV; Lin M; Liu X; Davis SM; Yan B
J Stroke Cerebrovasc Dis; 2014; 23(10):2888-2893. PubMed ID: 25440367
[TBL] [Abstract][Full Text] [Related]
54. Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI.
Schellinger PD; Jansen O; Fiebach JB; Heiland S; Steiner T; Schwab S; Pohlers O; Ryssel H; Sartor K; Hacke W
Stroke; 2000 Jun; 31(6):1318-28. PubMed ID: 10835451
[TBL] [Abstract][Full Text] [Related]
55. Results of intravenous thrombolysis within 4.5 to 6 hours and updated results within 3 to 4.5 hours of onset of acute ischemic stroke recorded in the Safe Implementation of Treatment in Stroke International Stroke Thrombolysis Register (SITS-ISTR): an observational study.
Ahmed N; Kellert L; Lees KR; Mikulik R; Tatlisumak T; Toni D;
JAMA Neurol; 2013 Jul; 70(7):837-44. PubMed ID: 23689267
[TBL] [Abstract][Full Text] [Related]
56. Peripheral Monocyte Count Predicts Outcomes in Patients with Acute Ischemic Stroke Treated with rtPA Thrombolysis.
Dong X; Nao J; Gao Y
Neurotox Res; 2020 Feb; 37(2):469-477. PubMed ID: 31478125
[TBL] [Abstract][Full Text] [Related]
57. Large-Vessel Occlusion Is Associated with Poor Outcome in Stroke Patients Aged 80 Years or Older Who Underwent Intravenous Thrombolysis.
Zhu W; Xiao L; Lin M; Liu X; Yan B
J Stroke Cerebrovasc Dis; 2016 Nov; 25(11):2712-2716. PubMed ID: 27522345
[TBL] [Abstract][Full Text] [Related]
58. Nonatrial Fibrillation was Associated With Early Neurological Improvement After Intravenous Thrombolysis With rt-PA in Patients With Acute Ischemic Stroke.
Liu J; Huang J; Xu H; Dai H
Neurologist; 2020 Mar; 25(2):28-32. PubMed ID: 32132497
[TBL] [Abstract][Full Text] [Related]
59. Changes in neutrophil, lymphocyte, platelet ratios and their relationship with NIHSS after rtPA and/or thrombectomy in ischemic stroke.
Kömürcü HF; Gözke E; Doğan Ak P; Kalyoncu Aslan I; Salt I; Özgenç Bi Er Çİ
J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):105004. PubMed ID: 32689579
[TBL] [Abstract][Full Text] [Related]
60. Risk of thrombolytic therapy for acute ischemic stroke in patients with current malignancy.
Masrur S; Abdullah AR; Smith EE; Hidalgo R; El-Ghandour A; Rordorf G; Schwamm LH
J Stroke Cerebrovasc Dis; 2011; 20(2):124-30. PubMed ID: 20598579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
